MTACU
Price:
$11.35
Market Cap:
$116.66M
MedTech Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the healthcare sector in the United States.. The company was incorporated in 2020 and is based in Greenwich, Connecticut.[Read more]
Industry
Shell Companies
IPO Date
2020-12-18
Stock Exchange
NASDAQ
Ticker
MTACU
According to MedTech Acquisition Corporation’s latest financial reports and current stock price. The company's current ROE is 284.08%. This represents a change of 540.04% compared to the average of 44.38% of the last 4 quarters.
The mean historical ROE of MedTech Acquisition Corporation over the last ten years is 65.68%. The current 284.08% ROE has changed 332.55% with respect to the historical average. Over the past ten years (40 quarters), MTACU's ROE was at its highest in in the December 2023 quarter at 136.90%. The ROE was at its lowest in in the September 2023 quarter at -15.15%.
Average
65.68%
Median
24.51%
Minimum
-13.93%
Maximum
227.61%
Discovering the peaks and valleys of MedTech Acquisition Corporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 750.54%
Maximum Annual ROE = 227.61%
Minimum Annual Increase = -259.78%
Minimum Annual ROE = -13.93%
Year | ROE | Change |
---|---|---|
2023 | 227.61% | 750.54% |
2022 | 26.76% | 20.24% |
2021 | 22.26% | -259.78% |
The current ROE of MedTech Acquisition Corporation (MTACU) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
92.21%
5-year avg
65.68%
10-year avg
65.68%
MedTech Acquisition Corporation’s ROE is less than Corner Growth Acquisition Corp. (47.79%), greater than Dune Acquisition Corporation (-47.37%), greater than CF Acquisition Corp. IV (-2.96%), less than Senior Connect Acquisition Corp. I (66.88%), less than Altitude Acquisition Corp. (69.45%),
Company | ROE | Market cap |
---|---|---|
47.79% | $111.99M | |
-47.37% | $22.25M | |
-2.96% | $221.29M | |
66.88% | $0 | |
69.45% | $85.77M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like MedTech Acquisition Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like MedTech Acquisition Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is MedTech Acquisition Corporation's ROE?
How is the ROE calculated for MedTech Acquisition Corporation (MTACU)?
What is the highest ROE for MedTech Acquisition Corporation (MTACU)?
What is the 3-year average ROE for MedTech Acquisition Corporation (MTACU)?
What is the 5-year average ROE for MedTech Acquisition Corporation (MTACU)?
How does the current ROE for MedTech Acquisition Corporation (MTACU) compare to its historical average?